Bieda et al., 2025 - Google Patents
The role of vitamin D and its supplementation in sarcoidosis–current statusBieda et al., 2025
View PDF- Document ID
- 9467882393964758871
- Author
- Bieda A
- Kondracka M
- Bielecki M
- Zapałowska A
- Kondracki K
- Szczepańska M
- Kozłowski W
- Publication year
External Links
Snippet
Introduction and aim. Sarcoidosis is a chronic autoimmune-related inflammatory disease characterized by non-caseating granuloma formation. The macrophages accumulating in granulomas express increased 1alpha hydroxylase activity. Increased extrarenal 1, 25 …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ebeling et al. | Management of endocrine disease: therapeutics of vitamin D | |
| Sintzel et al. | Vitamin D and multiple sclerosis: a comprehensive review | |
| Chen et al. | An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis | |
| Brouwer-Brolsma et al. | Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe | |
| Aapro et al. | Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer | |
| Blair et al. | Prevalence of vitamin D [25 (OH) D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients | |
| Burke et al. | Calcium and vitamin D in sarcoidosis: how to assess and manage | |
| Soilu-Hänninen et al. | A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis | |
| Mesquita et al. | Atopic dermatitis and vitamin D: facts and controversies | |
| Iolascon et al. | Effectiveness of calcifediol in improving muscle function in post-menopausal women: a prospective cohort study | |
| Saidenberg-Kermanac’h et al. | Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients | |
| Ahmed et al. | A comprehensive review on the impact of calcium and vitamin D insufficiency and allied metabolic disorders in females | |
| Wimalawansa | Achieving population vitamin D sufficiency will markedly reduce healthcare costs | |
| Wimalawansa | Effective and practical ways to overcome vitamin D deficiency | |
| Kupisz-Urbańska et al. | Vitamin D in elderly | |
| Kahl et al. | Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa | |
| Bieda et al. | The role of vitamin D and its supplementation in sarcoidosis–current status | |
| Silva et al. | Micronutrients deficiencies in rheumatoid arthritis patients | |
| Qu et al. | Research progress in the pharmacological actions of the multiple effects and selectivity of the vitamin D analogue paricalcitol: a narrative review | |
| Vucinic et al. | How to diagnose and manage difficult problems of calcium metabolism in sarcoidosis: an evidence-based review | |
| Port Louis et al. | Vitamin D and Immune Function: Unraveling the Connections | |
| Dechsupa et al. | Vitamin D supplementation improves muscle Mass, physical Function, and quality of life in patients with degenerative lumbar disease | |
| Galmarini et al. | Coronavirus, the immune system and vitamin D | |
| Gill et al. | The Effectiveness of Vitamin D Intake in Improving Symptoms and Relapses of Multiple Sclerosis: A Systematic Review | |
| Mansoori | PECULIARITIES OF VITAMIN D USE IN THE COMPLEX OF MENOPAUSAL HORMONAL THERAPY IN WOMEN |